Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor

Andrea Riccio, Angela Sparago, Gaetano Verde, Agostina De Crescenzo, Valentina Citro, Maria Vittoria Cubellis, Giovanni Battista Ferrero, Margherita Cirillo Silengo, Silvia Russo, Lidia Larizza, Flavia Cerrato

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The parent-of-origin-dependent expression of IGF2 and H19 is controlled by the imprinting center 1 (IC1) consisting of a methylation-sensitive chromatin insulator. IC1 is normally methylated on the paternal chromosome and nonmethylated on the maternal chromosome. We found that 22 cases in a large cohort of patients affected by Beckwith-Wiedemann syndrome (BWS) had IC1 methylated on both parental chromosomes, resulting in biallelic activation of IGF2 and biallelic silencing of H19. These individuals had marked macrosomia and high incidence of Wilms' tumor. A subset of these patients had 1.4- to 1.8-kb deletions with hypermethylation of the remaining IC1 region and fully penetrant BWS phenotype when transmitted maternally. Another subset of individuals with IC1 hypermethylation had a similar clinical phenotype but no mutation in the local vicinity. All these cases were sporadic and in at least two families affected and unaffected members shared the same maternal IC1 allele but not the abnormal maternal epigenotype. Similarly, no IC1 deletion was detected in 10 nonsyndromic Wilms' tumors with IC1 hypermethylation. In conclusion, methylation defects at the IGF2-H19 locus can result from inherited mutations of the imprinting center and have high recurrence risk or arise independently from the sequence context and not transmitted to the progeny.

Original languageEnglish
Title of host publicationEndocrine Development
Pages1-9
Number of pages9
Volume14
DOIs
Publication statusPublished - 2009

Publication series

NameEndocrine Development
Volume14
ISSN (Print)14217082
ISSN (Electronic)16622979

Fingerprint

Beckwith-Wiedemann Syndrome
Wilms Tumor
Chromosomes
Mothers
Methylation
Phenotype
Imprinting (Psychology)
Mutation
Chromatin
Alleles

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health
  • Endocrinology
  • Endocrine and Autonomic Systems

Cite this

Riccio, A., Sparago, A., Verde, G., De Crescenzo, A., Citro, V., Cubellis, M. V., ... Cerrato, F. (2009). Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor. In Endocrine Development (Vol. 14, pp. 1-9). (Endocrine Development; Vol. 14). https://doi.org/10.1159/000207461

Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor. / Riccio, Andrea; Sparago, Angela; Verde, Gaetano; De Crescenzo, Agostina; Citro, Valentina; Cubellis, Maria Vittoria; Ferrero, Giovanni Battista; Silengo, Margherita Cirillo; Russo, Silvia; Larizza, Lidia; Cerrato, Flavia.

Endocrine Development. Vol. 14 2009. p. 1-9 (Endocrine Development; Vol. 14).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Riccio, A, Sparago, A, Verde, G, De Crescenzo, A, Citro, V, Cubellis, MV, Ferrero, GB, Silengo, MC, Russo, S, Larizza, L & Cerrato, F 2009, Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor. in Endocrine Development. vol. 14, Endocrine Development, vol. 14, pp. 1-9. https://doi.org/10.1159/000207461
Riccio A, Sparago A, Verde G, De Crescenzo A, Citro V, Cubellis MV et al. Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor. In Endocrine Development. Vol. 14. 2009. p. 1-9. (Endocrine Development). https://doi.org/10.1159/000207461
Riccio, Andrea ; Sparago, Angela ; Verde, Gaetano ; De Crescenzo, Agostina ; Citro, Valentina ; Cubellis, Maria Vittoria ; Ferrero, Giovanni Battista ; Silengo, Margherita Cirillo ; Russo, Silvia ; Larizza, Lidia ; Cerrato, Flavia. / Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor. Endocrine Development. Vol. 14 2009. pp. 1-9 (Endocrine Development).
@inproceedings{d4d928dfd0ce4384bba70c37b42e56b5,
title = "Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor",
abstract = "The parent-of-origin-dependent expression of IGF2 and H19 is controlled by the imprinting center 1 (IC1) consisting of a methylation-sensitive chromatin insulator. IC1 is normally methylated on the paternal chromosome and nonmethylated on the maternal chromosome. We found that 22 cases in a large cohort of patients affected by Beckwith-Wiedemann syndrome (BWS) had IC1 methylated on both parental chromosomes, resulting in biallelic activation of IGF2 and biallelic silencing of H19. These individuals had marked macrosomia and high incidence of Wilms' tumor. A subset of these patients had 1.4- to 1.8-kb deletions with hypermethylation of the remaining IC1 region and fully penetrant BWS phenotype when transmitted maternally. Another subset of individuals with IC1 hypermethylation had a similar clinical phenotype but no mutation in the local vicinity. All these cases were sporadic and in at least two families affected and unaffected members shared the same maternal IC1 allele but not the abnormal maternal epigenotype. Similarly, no IC1 deletion was detected in 10 nonsyndromic Wilms' tumors with IC1 hypermethylation. In conclusion, methylation defects at the IGF2-H19 locus can result from inherited mutations of the imprinting center and have high recurrence risk or arise independently from the sequence context and not transmitted to the progeny.",
author = "Andrea Riccio and Angela Sparago and Gaetano Verde and {De Crescenzo}, Agostina and Valentina Citro and Cubellis, {Maria Vittoria} and Ferrero, {Giovanni Battista} and Silengo, {Margherita Cirillo} and Silvia Russo and Lidia Larizza and Flavia Cerrato",
year = "2009",
doi = "10.1159/000207461",
language = "English",
isbn = "9783805590419",
volume = "14",
series = "Endocrine Development",
pages = "1--9",
booktitle = "Endocrine Development",

}

TY - GEN

T1 - Inherited and sporadic epimutations at the IGF2-H19 locus in beckwith-wiedemann syndrome and wilms' tumor

AU - Riccio, Andrea

AU - Sparago, Angela

AU - Verde, Gaetano

AU - De Crescenzo, Agostina

AU - Citro, Valentina

AU - Cubellis, Maria Vittoria

AU - Ferrero, Giovanni Battista

AU - Silengo, Margherita Cirillo

AU - Russo, Silvia

AU - Larizza, Lidia

AU - Cerrato, Flavia

PY - 2009

Y1 - 2009

N2 - The parent-of-origin-dependent expression of IGF2 and H19 is controlled by the imprinting center 1 (IC1) consisting of a methylation-sensitive chromatin insulator. IC1 is normally methylated on the paternal chromosome and nonmethylated on the maternal chromosome. We found that 22 cases in a large cohort of patients affected by Beckwith-Wiedemann syndrome (BWS) had IC1 methylated on both parental chromosomes, resulting in biallelic activation of IGF2 and biallelic silencing of H19. These individuals had marked macrosomia and high incidence of Wilms' tumor. A subset of these patients had 1.4- to 1.8-kb deletions with hypermethylation of the remaining IC1 region and fully penetrant BWS phenotype when transmitted maternally. Another subset of individuals with IC1 hypermethylation had a similar clinical phenotype but no mutation in the local vicinity. All these cases were sporadic and in at least two families affected and unaffected members shared the same maternal IC1 allele but not the abnormal maternal epigenotype. Similarly, no IC1 deletion was detected in 10 nonsyndromic Wilms' tumors with IC1 hypermethylation. In conclusion, methylation defects at the IGF2-H19 locus can result from inherited mutations of the imprinting center and have high recurrence risk or arise independently from the sequence context and not transmitted to the progeny.

AB - The parent-of-origin-dependent expression of IGF2 and H19 is controlled by the imprinting center 1 (IC1) consisting of a methylation-sensitive chromatin insulator. IC1 is normally methylated on the paternal chromosome and nonmethylated on the maternal chromosome. We found that 22 cases in a large cohort of patients affected by Beckwith-Wiedemann syndrome (BWS) had IC1 methylated on both parental chromosomes, resulting in biallelic activation of IGF2 and biallelic silencing of H19. These individuals had marked macrosomia and high incidence of Wilms' tumor. A subset of these patients had 1.4- to 1.8-kb deletions with hypermethylation of the remaining IC1 region and fully penetrant BWS phenotype when transmitted maternally. Another subset of individuals with IC1 hypermethylation had a similar clinical phenotype but no mutation in the local vicinity. All these cases were sporadic and in at least two families affected and unaffected members shared the same maternal IC1 allele but not the abnormal maternal epigenotype. Similarly, no IC1 deletion was detected in 10 nonsyndromic Wilms' tumors with IC1 hypermethylation. In conclusion, methylation defects at the IGF2-H19 locus can result from inherited mutations of the imprinting center and have high recurrence risk or arise independently from the sequence context and not transmitted to the progeny.

UR - http://www.scopus.com/inward/record.url?scp=65549151250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549151250&partnerID=8YFLogxK

U2 - 10.1159/000207461

DO - 10.1159/000207461

M3 - Conference contribution

C2 - 19293570

AN - SCOPUS:65549151250

SN - 9783805590419

VL - 14

T3 - Endocrine Development

SP - 1

EP - 9

BT - Endocrine Development

ER -